We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
(-6%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-17.18%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$17.1M |
| 2 |
MOMO
Hello Group
MOMO
|
+$5.31M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
+$4.25M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$4.13M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
+$94.3M |
| 2 |
Vipshop
VIPS
|
+$47.3M |
| 3 |
DigitalBridge
DBRG
|
+$39.3M |
| 4 |
Brookdale Senior Living
BKD
|
+$37.8M |
| 5 |
Criteo
CRTO
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Norfolk Southern
NSC
$75.4B
| $949K | 0.06% |
5,090
+3,490
| +218% | +$604K |
|
152
Albemarle
ALB
$13.4B
| $942K | 0.06% |
11,600
+500
| +5% | +$40.9K |
|
|
MTEM
153
DELISTED
Molecular Templates, Inc.
MTEM
| $940K | 0.06% |
10,866
+3,064
| +39% | +$225K |
|
154
Cartesian Therapeutics
RNAC
$218M
| $938K | 0.06% |
14,611
+8,844
| +153% | +$561K |
|
155
McKesson
MCK
$104B
| $935K | 0.06% |
7,985
-3,100
| -28% | -$383K |
|
156
Liberty Global Class A
LBTYA
$3.59B
| $934K | 0.06% |
+37,000
| New | +$904K |
|
157
Workday
WDAY
$41.5B
| $932K | 0.06% |
+4,900
| New | +$891K |
|
158
AT&T
T
$164B
| $915K | 0.06% |
39,058
| – | – |
|
159
T-Mobile US
TMUS
$195B
| $899K | 0.06% |
13,000
| – | – |
|
160
Quanta Services
PWR
$84.2B
| $890K | 0.06% |
+23,800
| New | +$831K |
|
161
Hormel Foods
HRL
$14.2B
| $888K | 0.06% |
+20,000
| New | +$856K |
|
162
Rhythm Pharmaceuticals
RYTM
$7.31B
| $887K | 0.06% |
29,720
| – | – |
|
163
NOV
NOV
$6.84B
| $875K | 0.06% |
33,000
| – | – |
|
164
Becton Dickinson
BDX
$46.4B
| $872K | 0.06% |
3,618
-308
| -8% | -$72.8K |
|
|
VIRX
165
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $863K | 0.05% |
+20,714
| New | +$469K |
|
166
IBM
IBM
$213B
| $828K | 0.05% |
6,187
| – | – |
|
167
Estee Lauder
EL
$30.4B
| $824K | 0.05% |
5,010
+300
| +6% | +$44.1K |
|
168
Intuit
INTU
$91.1B
| $815K | 0.05% |
3,145
| – | – |
|
|
SCHW
169
Charles Schwab
SCHW
$182B
| $811K | 0.05% |
19,000
| – | – |
|
170
Agilent Technologies
A
$39.6B
| $810K | 0.05% |
10,160
| – | – |
|
171
Pfizer
PFE
$143B
| $787K | 0.05% |
19,604
-52,209
| -73% | -$2.09M |
|
|
INFI
172
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $786K | 0.05% |
418,296
+40,000
| +11% | +$58.5K |
|
173
Oracle
ORCL
$339B
| $779K | 0.05% |
14,655
| – | – |
|
|
CDTX
174
DELISTED
Cidara Therapeutics
CDTX
| $773K | 0.05% |
15,334
| – | – |
|
175
Goldman Sachs
GS
$289B
| $765K | 0.05% |
4,000
-2,915
| -42% | -$562K |
|
Similar funds
NC
T2I
BA
IAA
THL
MHC
BWM
KHCM
Fosun International's Q1 2019 Portfolio in Review
As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Fosun International opened a new position in Baozun worth $20.3M.
- Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
- Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
- Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
- Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
- Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
- Fosun International opened 45 new positions and closed 37 in Q1 2019.
- Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.
Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.